ISSDP

The International Society for the Study of Drug Policy

Privacy & Cookies: This site uses cookies. By continuing to use this website, you agree to their use.
To find out more, including how to control cookies, see here: Cookies Policy
The International Society for the Study of Drug Policy
English Español
  • Conferences & Events
    • Future Conferences & Events
    • Past Conferences & Events
    • Webinars
    • Past Webinars
    • Webinar Recordings (for Members)
  • News and Announcements
    • Current News & Announcements
    • Newsletters
    • Archived News & Announcements
  • Bibliography
    • Introduction
    • All Publications
    • Bibliography Archive
    • Prevalence
    • Production and Supply
    • Economics
    • Domestic Policy Issues
    • International Policy Issues
    • Interventions – Prevention
    • Interventions – Treatment
    • Interventions – Law Enforcement
    • Interventions – Harm Reduction
  • Membership
  • Who we are
  • Working Group
  • By-laws
  • Annual Awards
  • IJDP

Bibliography: All Publications


Members of the European Parliament endorse a broader mandate for the EMCDDA

2nd December 2022

Members of the European Parliament (MEPs) from the Civil Liberties Committee (LIBE) adopted a report creating the European Union Drugs Agency and endowing it with new competences (EMCDDA)

Categories: International Policy Issues

Drug and alcohol services – co-occurring substance use and mental health concerns: literature and evidence review

2nd December 2022

This report provides a rapid review of the literature on co-occurring substance use and mental health concerns and the integration of mental health and substance use services in Scotland (Scottish Government)

Categories: Interventions - Harm Reduction, Interventions - Treatment, Prevalence

HIV Action Plan monitoring and evaluation framework

2nd December 2022

The 2021 data has shown positive signs of recovery, but that recovery is uneven. The number of all people with diagnosed HIV infection and in care who were treated and virally suppressed remained extremely high between 2019 and 2021 (UK Government)

Categories: Bibliography, Interventions - Harm Reduction, Interventions - Treatment, Prevalence

Categories: Interventions - Harm Reduction, Interventions - Treatment, Prevalence

Trends in the availability and types of drugs sold on the internet via cryptomarkets, October 2021 – September 2022

1st December 2022

This bulletin series reports on trends in the availability and types of drugs sold on the internet via cryptomarkets over a 12-month period (a new bulletin is released typically every four months). The current bulletin focuses on analysis of drug listings on cryptomarkets from 1 October 2021 to 30 September 2022 (NDARC)

Categories: Bibliography, Prevalence, Production and Supply

Categories: Prevalence, Production and Supply

Drug Overdose Deaths in Adults Aged 65 and Over: United States, 2000–2020

30th November 2022

Between 2000 and 2020, age-adjusted rates of drug overdose deaths for adults aged 65 and over increased from 2.4 to 8.8 deaths per 100,000 standard population (CDC)

Categories: Bibliography, Prevalence

Categories: Prevalence

Drug-Related and Drug-Misuse Deaths 2011-2021

25th November 2022

The 2011-2021 edition of Drug-related and drug-misuse deaths contains a revised version of drug-misuse deaths which makes data for Northern Ireland comparable with England and Wales

Categories: Bibliography, Prevalence

Categories: Prevalence

Deaths of homeless people in England and Wales: 2021 registrations

24th November 2022

Almost two in five deaths of homeless people were related to drug poisoning in 2021 (259 estimated deaths; 35.0% of the total number), consistent with previous years (ONS)

Categories: Bibliography, Prevalence

Categories: Prevalence

Drug-related hospital statistics – Scotland 2021 to 2022

23rd November 2022

This release by Public Health Scotland (PHS) presents information on hospital activity relating to illicit drug use in Scotland during the period 1996/97 to 2021/22. The topics covered include: the number of hospital stays, the number and characteristics of patients, substances used and geographical variations. These data are published in a dashboard and full report

Categories: Bibliography, Interventions - Treatment, Prevalence

Categories: Interventions - Treatment, Prevalence

Experiences of Harm Reduction Service Providers During Dual Public Health Emergencies in Canada

23rd November 2022

This study initially set out to gain a better understanding of the effect of the overdose emergency from harm reduction service providers’ perspective. However, with the onset of COVID-19, CCSA expanded the study to identify the additional effects of dual public health emergencies (CCSA)

Categories: Bibliography, Domestic Policy Issues, Interventions - Harm Reduction

Categories: Domestic Policy Issues, Interventions - Harm Reduction

National Mission on Drugs: annual report 2021 to 2022

22nd November 2022

Sets out the progress made between January 2021 and 31 March 2022 by national government, local government and third sector partners towards reducing drug deaths and improving the lives of those impacted by drugs in Scotland Download (Scottish Government)

Categories: Bibliography, Domestic Policy Issues, Interventions - Harm Reduction, Interventions - Treatment

Categories: Domestic Policy Issues, Interventions - Harm Reduction, Interventions - Treatment

EMCDDA releases new findings on drug markets in the eastern and southern European Neighbourhood Policy regions

22nd November 2022

The emergence of new drug trafficking routes, the expansion of online markets, and the availability of a broader spectrum of substances, are among the findings highlighted in two new reports published today by the EU drugs agency (EMCDDA)

Categories: Bibliography, Production and Supply

Categories: Production and Supply

Recreational use of nitrous oxide — a growing concern for Europe

21st November 2022

The purpose of this report is to examine the current situation, risks and responses to the recreational use of nitrous oxide in Europe (EMCDDA)

Categories: Bibliography, Prevalence

Categories: Prevalence

Global State of Harm Reduction

10th November 2022

The Global State of Harm Reduction is the only report that provides an independent analysis of harm reduction in the world. Now in its the eighth edition, the Global State of Harm Reduction 2022 is the most comprehensive global mapping of harm reduction responses to drug use, HIV and viral hepatitis (HRI)

Categories: Bibliography, Interventions - Harm Reduction

Categories: Interventions - Harm Reduction

Scottish Health Survey 2021 published

9th November 2022

Three percent of adults reported ever having a problem with drugs. Twelve per cent of adults reported using drugs in the previous 12 months. Prevalence was highest amongst those aged 16-24 (22%) (Scottish Government)

Categories: Bibliography, Prevalence

Categories: Prevalence

Estimated numbers of people prescribed opioid substitution therapy in Scotland

9th November 2022

In 2021/22, Opioid Substitution Therapy (OST) was prescribed to an estimated minimum of 29,600 people in Scotland. This was a small increase compared to the 2020/21 estimate (29,416) (Public Health Scotland)

Categories: Bibliography, Interventions - Harm Reduction, Prevalence

Categories: Interventions - Harm Reduction, Prevalence

Results and challenges of running the Web Survey on Drugs in Luxembourg: a major contribution to understanding the drug situation

7th November 2022

This paper shows how the second wave of the European Web Survey on Drugs (EWSD) led to a better understanding of the drug situation in Luxembourg. Until the EWSD, detailed information on the drug situation in Luxembourg was very limited, with only a few surveys, often small-scale, having been conducted in the country since the late 1990s (EMCDDA)

Categories: Bibliography, International Policy Issues, Prevalence

Categories: International Policy Issues, Prevalence

New report finds 171 drug-related hospitalisations per day in Australia in 2020-21

3rd November 2022

There were 62,486 drug-related hospitalisations (excluding alcohol and tobacco) among Australians in 2020-21, according to a new report released today by the Drug Trends program at the National Drug and Alcohol Research Centre (NDARC), UNSW Sydney

Categories: Bibliography, Prevalence

Categories: Prevalence

Global State of Harm Reduction

2nd November 2022

Now in its the eighth edition, the Global State of Harm Reduction 2022 is the most comprehensive global mapping of harm reduction responses to drug use, HIV and viral hepatitis  Full report Summary (Harm Reduction International)

Categories: Bibliography, International Policy Issues, Interventions - Harm Reduction

Categories: International Policy Issues, Interventions - Harm Reduction

Afghanistan opium cultivation in 2022 up by 32 per cent: UNODC survey

1st November 2022

The 2022 opium crop in Afghanistan is the most profitable in years with cultivation up by nearly one-third and prices soaring, even as the country is gripped by cascading humanitarian and economic crises, according to a new research brief from the United Nations Office on Drugs and Crime (UNODC)

Categories: Bibliography, Production and Supply

Categories: Production and Supply

Cutting the head off the snake

31st October 2022

Addressing the role technology plays in the county lines model – final report (Crest)

Categories: Bibliography, Interventions - Harm Reduction, Interventions - Prevention

Categories: Interventions - Harm Reduction, Interventions - Prevention
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 96
  • Next Page »

Search the Bibliography

Bibliography Menu

  • Introduction
  • All Publications
  • Prevalence
  • Production and Supply
  • Economics
  • Domestic Policy Issues
  • International Policy Issues
  • Interventions – Prevention
  • Interventions – Treatment
  • Interventions – Law Enforcement
  • Interventions – Harm Reduction

Bibliography Archive

calendar-iconBibliography Archive ››

Navigation

  • Home
  • Future Conferences & Events
  • News & Announcements
  • Bibliography
  • Working Group
  • Annual Awards
  • Membership
  • Who we are
  • By-laws
  • IJDP
  • Contact

ISSDP on Twitter

Tweets by @ISSDrugPolicy

Contact ISSDP

For further information about the ISSDP, including membership queries, please contact us.

Please Share ISSDP

Copyright © 2023 The International Society for the Study of Drug Policy

The International Society for the Study of Drug Policy is registered in England as a charitable incorporated organisation. Charity no: 1177654